CNTX
Price
$0.84
Change
-$0.03 (-3.45%)
Updated
Apr 17 closing price
Capitalization
75.63M
19 days until earnings call
OCUL
Price
$7.31
Change
+$0.14 (+1.95%)
Updated
Apr 17 closing price
Capitalization
1.16B
24 days until earnings call
Ad is loading...

CNTX vs OCUL

Header iconCNTX vs OCUL Comparison
Open Charts CNTX vs OCULBanner chart's image
Context Therapeutics
Price$0.84
Change-$0.03 (-3.45%)
Volume$45.59K
Capitalization75.63M
Ocular Therapeutix
Price$7.31
Change+$0.14 (+1.95%)
Volume$1.63M
Capitalization1.16B
CNTX vs OCUL Comparison Chart
Loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTX vs. OCUL commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and OCUL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (CNTX: $0.84 vs. OCUL: $7.31)
Brand notoriety: CNTX and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 27% vs. OCUL: 99%
Market capitalization -- CNTX: $75.63M vs. OCUL: $1.16B
CNTX [@Biotechnology] is valued at $75.63M. OCUL’s [@Biotechnology] market capitalization is $1.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTX is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 5 TA indicator(s) are bullish while OCUL’s TA Score has 5 bullish TA indicator(s).

  • CNTX’s TA Score: 5 bullish, 4 bearish.
  • OCUL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both CNTX and OCUL are a good buy in the short-term.

Price Growth

CNTX (@Biotechnology) experienced а +24.11% price change this week, while OCUL (@Biotechnology) price change was +14.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

CNTX is expected to report earnings on Aug 06, 2025.

OCUL is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($1.16B) has a higher market cap than CNTX($75.6M). OCUL YTD gains are higher at: -14.403 vs. CNTX (-19.705). CNTX has higher annual earnings (EBITDA): -32.54M vs. OCUL (-176.14M). OCUL has more cash in the bank: 392M vs. CNTX (84.8M). CNTX has less debt than OCUL: CNTX (244K) vs OCUL (75.8M). OCUL has higher revenues than CNTX: OCUL (63.7M) vs CNTX (0).
CNTXOCULCNTX / OCUL
Capitalization75.6M1.16B7%
EBITDA-32.54M-176.14M18%
Gain YTD-19.705-14.403137%
P/E RatioN/AN/A-
Revenue063.7M-
Total Cash84.8M392M22%
Total Debt244K75.8M0%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
77
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTXOCUL
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGFFX38.090.26
+0.69%
American Funds Intl Gr and Inc F2
FNGRX15.18N/A
N/A
Franklin Intl Growth R
CHCCX3.36N/A
N/A
AB Discovery Growth C
JACRX13.44N/A
N/A
Easterly Global Real Estate C
VLSAX15.79N/A
N/A
Virtus KAR Long/Short Equity A

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and OBIO have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and OBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-2.54%
OBIO - CNTX
33%
Poorly correlated
-0.35%
ELVN - CNTX
31%
Poorly correlated
+2.86%
OCUL - CNTX
30%
Poorly correlated
+1.95%
FATE - CNTX
30%
Poorly correlated
+5.71%
SLN - CNTX
30%
Poorly correlated
+8.28%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+1.95%
EYPT - OCUL
54%
Loosely correlated
+2.25%
DNLI - OCUL
48%
Loosely correlated
+1.51%
BHVN - OCUL
48%
Loosely correlated
+9.05%
KRYS - OCUL
46%
Loosely correlated
+2.35%
APGE - OCUL
45%
Loosely correlated
+3.34%
More